These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

223 related articles for article (PubMed ID: 21654022)

  • 41. Use of exhaled breath condensate to investigate occupational lung diseases.
    Corradi M; Gergelova P; Mutti A
    Curr Opin Allergy Clin Immunol; 2010 Apr; 10(2):93-8. PubMed ID: 19996962
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Biomarkers of exposure in community settings.
    Metcalf SW; Orloff KG
    J Toxicol Environ Health A; 2004 Apr 23-May 28; 67(8-10):715-26. PubMed ID: 15192864
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Exhaled nitric oxide and biomarkers in exhaled breath condensate indicate the presence, severity and control of childhood asthma.
    Robroeks CM; van de Kant KD; Jöbsis Q; Hendriks HJ; van Gent R; Wouters EF; Damoiseaux JG; Bast A; Wodzig WK; Dompeling E
    Clin Exp Allergy; 2007 Sep; 37(9):1303-11. PubMed ID: 17845410
    [TBL] [Abstract][Full Text] [Related]  

  • 44. A review of the USEPA's single breath canister (SBC) method for exhaled volatile organic biomarkers.
    Lindstrom AB; Pleil JD
    Biomarkers; 2002; 7(3):189-208. PubMed ID: 12141064
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Smart sensor systems for human health breath monitoring applications.
    Hunter GW; Xu JC; Biaggi-Labiosa AM; Laskowski D; Dutta PK; Mondal SP; Ward BJ; Makel DB; Liu CC; Chang CW; Dweik RA
    J Breath Res; 2011 Sep; 5(3):037111. PubMed ID: 21896970
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Biomarkers in asthma.
    Murugan A; Prys-Picard C; Calhoun WJ
    Curr Opin Pulm Med; 2009 Jan; 15(1):12-8. PubMed ID: 19077700
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Implications of chemical mixtures in public health practice.
    de Rosa CT; El-Masri HA; Pohl H; Cibulas W; Mumtaz MM
    J Toxicol Environ Health B Crit Rev; 2004; 7(5):339-50. PubMed ID: 15371239
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Human biomonitoring activities--programmes by industry.
    Boogaard PJ
    Int J Hyg Environ Health; 2007 May; 210(3-4):259-61. PubMed ID: 17275410
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Chemical Safety for Sustainability (CSS): human in vivo biomonitoring data for complementing results from in vitro toxicology--a commentary.
    Pleil JD; Williams MA; Sobus JR
    Toxicol Lett; 2012 Dec; 215(3):201-7. PubMed ID: 23116968
    [TBL] [Abstract][Full Text] [Related]  

  • 50. A linear model relating breath concentrations to environmental exposures: application to a chamber study of four volunteers exposed to volatile organic chemicals.
    Wallace L; Pellizzari E; Gordon S
    J Expo Anal Environ Epidemiol; 1993; 3(1):75-102. PubMed ID: 8518547
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Advancing exposure characterization for chemical evaluation and risk assessment.
    Cohen Hubal EA; Richard A; Aylward L; Edwards S; Gallagher J; Goldsmith MR; Isukapalli S; Tornero-Velez R; Weber E; Kavlock R
    J Toxicol Environ Health B Crit Rev; 2010 Feb; 13(2-4):299-313. PubMed ID: 20574904
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Biological monitoring of carcinogens: current status and perspectives.
    Pavanello S; Lotti M
    Arch Toxicol; 2012 Apr; 86(4):535-41. PubMed ID: 22159923
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Environmental chemicals in people: challenges in interpreting biomonitoring information.
    LaKind JS; Barraj L; Tran N; Aylward LL
    J Environ Health; 2008 May; 70(9):61-4. PubMed ID: 18517157
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Analysis of exhaled breath for disease detection.
    Amann A; Miekisch W; Schubert J; Buszewski B; Ligor T; Jezierski T; Pleil J; Risby T
    Annu Rev Anal Chem (Palo Alto Calif); 2014; 7():455-82. PubMed ID: 25014347
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Examination of exhaled breath condensate in patients with asthma and chronic obstructive pulmonary diseases].
    Cáp P; Pehal F
    Cas Lek Cesk; 2004; 143(11):742-6; discussion 746-7. PubMed ID: 15628568
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Blood-borne biomarkers and bioindicators for linking exposure to health effects in environmental health science.
    Wallace MA; Kormos TM; Pleil JD
    J Toxicol Environ Health B Crit Rev; 2016; 19(8):380-409. PubMed ID: 27759495
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Breath biomarkers in toxicology.
    Pleil JD
    Arch Toxicol; 2016 Nov; 90(11):2669-2682. PubMed ID: 27585664
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Exhaled NO and breath condensate.
    Baraldi E; Carraro S
    Paediatr Respir Rev; 2006; 7 Suppl 1():S20-2. PubMed ID: 16798565
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Implications of the exposome for exposure science.
    Rappaport SM
    J Expo Sci Environ Epidemiol; 2011; 21(1):5-9. PubMed ID: 21081972
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Blood and exhaled air can be used for biomonitoring of hydrofluorocarbon exposure.
    Ernstgård L; Sjögren B; Gunnare S; Johanson G
    Toxicol Lett; 2014 Feb; 225(1):102-9. PubMed ID: 24296009
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.